๐ฐ Dexcel Pharma News
Page 2 - Dexcel Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dexcel Pharma. Real-time updates on events, politics, business and more.
August 9, 2022
SK Biopharmaceuticals is eligible to receive milestones for future approval and commercialization in Canada and IsraelPANGYO, South Korea, Aug. 9,...
July 12, 2022
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 12, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce that it
May 17, 2022
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
May 16, 2022
Durham's Kriya Therapeutics just added $270 million to its coffers, bringing its total raised to date to roughly $450 million for novel gene therapies
April 27, 2022
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
November 25, 2021
For the first time, "Globes", in collaboration with international market and consumer data company Statista, presents the 150 best employers in Israel.
October 18, 2021
Editor's note: This story is another in the "Startup Spotlight" series which brings into greater view emerging and new technologies. This post is from the N.C.
October 15, 2021
Kriya Therapeutics is launching a new division, Kriya Ophthalmology, focused on developing gene therapies for rare and prevalent ocular diseases.
August 16, 2021
If you injure your elbow, surgery can help. If you lose a leg, prostheses are available. But problems within the brain are more difficult to treat, and for stroke victims, rehabilitation is largely left to the body’s own repair mechanisms. BrainQ aims to change that with a device that stimulates the damaged part of the […]
August 16, 2021
The round was led by Hanaco Ventures, alongside Dexcel Pharma, and Peregrine Ventures, bringing the total funding to over $50 million. Funds to be used to support companyโs pivotal trials for stroke survivors in U.S. hospitals